Markets
BSE See NSE See 39,046.34
85.55 (0.22%)
collapse Related Readings collapse

Your Stock Queries

| 9/6/2012 9:00 PM Thursday

MAHANAGAR TELEPHONE NIGAM

I am holding 320 shares of Mahanagar Telephone Nigam purchased at Rs 38 per share. What should I do with these now?

- S Joshi, Satara, Maharashtra

Mahanagar Telephone Nigam, BSE/NSE Code 500108/MTNL, with a face value of Rs 10, is currently trading at Rs 40.70, which is at a seven per cent premium to your acquisition cost. Its 52-week high/low stand at Rs 42 and Rs 19 respectively.

MTNL provides telecommunications services in Delhi and Mumbai. It offers various telecommunication services such as fixed landline and cellular telephone services. It also provides data services and internet protocol television, voice over internet protocol, infrastructure, multi-protocol label switching and video phone services.

MTNL has been struggling for quite some time now, and its financial performance for Q1FY13 has not been encouraging at all. The topline remained almost flat with de-growth of 1.19 per cent on a YoY basis, and stood at Rs 833 crore as against Rs 843 crore for Q1FY12. It reported a loss of Rs 1059 crore for the quarter as against a loss of Rs 850 crore for Q1FY12. This has been the fifth consecutive quarter in which the company has been in the red. The most alarming part is that in these five quarters, the losses have only mounted higher. The company had been debt-free till FY11, but due to the 3G allotment that it had to fund, it now has a debt of Rs 7400 crore on its books. We suggest that you exit the counter and look for other attractive investment horizons.

ADANI POWER

I am holding 100 share of Adani Power purchased at a price of Rs 63 per share. Can I hold these for the long term?

- Vighnesh Pagi, Via Email

Adani Power, BSE/NSE Code 533096/ADANIPOWER, with a face value of Rs 10, is currently trading at Rs 39.45 with a 52-week high/low of Rs 97 and Rs 40 respectively. The stock is currently trading at a 37 per cent discount to your acquisition cost.

Adani Power, together with its subsidiaries, engages in the generation and transmission of power in India. The company has more than doubled its capacity from 2 GW to 4.6 GW in FY12 and is slated to further increase its capacity to 6.6 GW by the end of FY13. But there are certain factors that are playing spoilsport. Higher than estimated fuel costs, rupee depreciation impacting operational costs even further, delays in power evacuation lines and tariff disputes with its counterparts for two projects at Mundra and Tiroda are some of these. In addition, the company has an unhedged foreign debt exposure of USD1.2 billion, which is a matter of concern. The impact of all this was evident in its FY12 results, wherein it reported a loss of Rs 93 crore compared to a profit of Rs 520 crore in FY11.

On the financial front, the company’s performance for Q1FY13 has been quite muted. While the topline stood at Rs 1463 crore, witnessing a growth of 78 per cent on a YoY basis, it reported a loss of Rs 792 crore for the same period. The interest cost has gone up several notches and stands at Rs 486 crore as against Rs 88.63 crore for Q1FY12, which is one of the main reasons for the dismal performance. The stock trades at an EV/EBITDA of 27.18x and its debt-to-equity ratio stands at 5.19x. We, at DSIJ, are not bullish on the sector as a whole and suggest that you exit the stock even if you have to book losses.

 

Find More Articles on: DSIJ Magazine, Portfolio Guide, Stock Recommendations, Fundamental Picks, Product, Large Cap, Mid Cap, PSU

«« First « Previous |1 2 | Last ››
news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

MIDHANI and HAL partner to develop bio implants

Geyatee Deshpande / Article rating: 5.0

Mishra Dhatu Nigam Limited (MIDHANI) signs an MoU with Hindustan Antibiotics Limited (HAL). This MoU will provide synergy for quality manufacturing of MIDHANI’s Bio-medical Implants and get access to the pan-India distribution of HAL. This partnership is aimed to gain advantage from the strengths of both the companies and benefit users of Bio-medical products in India.

12345678910Last

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Logistics sector will play a vital role in making the concept of ‘Make in India’ a success. This will be further aided by some of the recent steps taken by Government of India such as granting of infra sector status to logistics sector.

Best and worst Performing Sector Funds of Year 2017

Best and worst Performing Sector Funds of Year 2017

As the year-end has approached most of you are eager to know the mutual fund movers and shakers of the year 2017. Read on to find the performance of various sector dedicated funds.

Markets may start positive, but volatility likely due to F&O expiry

Markets may start positive, but volatility likely due to F&O expiry

The start of the F&O expiry day is likely to be in the green, but volatility may creep in with the progress of the session. The SGX Nifty suggests that the Nifty could open at 10,525 with gains of 32 points at the opening bell. 

Pidilite announces buyback of Rs 500 crore

Pidilite announces buyback of Rs 500 crore

The buyback offer comprises purchase of up to 50,00,000 equity shares. The buyback offer size comprises 0.975 per cent of the total paid-up equity capital of the company.

Bank Nifty drags markets to close in the red

Bank Nifty drags markets to close in the red

The late session fall in Bank Nifty changed the direction of the market, leading to a marginal fall in the benchmark indices. Bank Nifty yet again resisted at its multiple point downward sloping trendline level at 25733.

Six major underperforming MF schemes having higher expense ratios

Six major underperforming MF schemes having higher expense ratios

Mutual funds with a large size of assets under management (AUMs) are supposed to have lower expense ratios. However, there are schemes with large AUMs but having higher expense ratios and generating lower returns. 

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma index has come in as the healer in an otherwise sluggish market. Index has given a consolidation breakout at the 9420 level today and if the it sustains 9420, followed by 9628 on the upside, it has a long way to go.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.35 p.m. on December 27.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 27 opened gap down. BSE Sensex is trading at 34,068.15, up by 57.54 points and the Nifty is trading at 10,539.45, up by 7.95 points.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.75 lakh contracts with a turnover of Rs. 5,19,204.72 crore.